Effect of Dual RAAS Blockade and Intensive BP Lowering on Risk of End-Stage Kidney Disease and Death in Autosomal Dominant Polycystic Kidney Disease: Long-term Follow-up of the HALT-PKD Trials.

Autor: Ku E; Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, California; Department of Pediatrics, Division of Pediatric Nephrology, University of California, San Francisco, San Francisco, California; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California. Electronic address: elaine.ku@ucsf.edu., Copeland TP; Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, California., McCulloch CE; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California., Abebe KZ; Center for Biostatistics & Qualitative Methodology, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Chonchol M; Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Perrone RD; Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts., Rahbari-Oskoui FF; Division of Nephrology, Department of Medicine, Emory University, Atlanta, Georgia., Yu ASL; Division of Nephrology, Department of Medicine, University of Kansas Medical Center, Kansas City, Kansas., Steinman T; School of Medicine, Harvard University, Boston, Massachusetts., Chapman A; Department of Medicine, Division of Nephrology, University of Chicago, Chicago, Illinois., Sarnak MJ; Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts.

Publikováno v: American journal of kidney diseases : the official journal of the National Kidney Foundation [Am J Kidney Dis] 2024 Aug 16. Date of Electronic Publication: 2024 Aug 16.

Effect of Intensive Blood Pressure Control on Kidney Outcomes: Long-Term Electronic Health Record-Based Post-Trial Follow-Up of SPRINT.

Autor: Drawz PE; Division of Nephrology and Hypertension, University of Minnesota, Minneapolis, Minnesota., Lenoir KM; Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Rai NK; Division of Nephrology and Hypertension, University of Minnesota, Minneapolis, Minnesota., Rastogi A; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California., Chu CD; Department of Medicine, University of California, San Francisco, San Francisco, California., Rahbari-Oskoui FF; Emory University School of Medicine, Atlanta, Georgia., Whelton PK; Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana., Thomas G; Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio., McWilliams A; Department of Internal Medicine, Center for Outcomes Research and Evaluation, Atrium Health, Charlotte, North Carolina., Agarwal AK; Department of Medicine, Veterans Affairs Central California Health Care System, Fresno, California., Suarez MM; Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida., Dobre M; Division of Nephrology and Hypertension, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio., Powell J; Division of General Internal Medicine, Brody School of Medicine, East Carolina University, Greenville, North Carolina., Rocco MV; Section on Nephrology, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Lash JP; Division of Nephrology, University of Illinois at Chicago, Chicago, Illinois., Oparil S; Division of Cardiovascular Disease, University of Alabama-Birmingham, Birmingham, Alabama., Raj DS; Division of Kidney Diseases and Hypertension, George Washington University, Washington, DC., Dwyer JP; Division of Nephrology and Hypertension, University of Utah Health, Salt Lake City, Utah., Rahman M; Division of Nephrology and Hypertension, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio., Soman S; Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, Michigan., Townsend RR; Perelman School of Medicine University of Pennsylvania, Philadelphia, Pennsylvania., Pemu P; Morehouse School of Medicine, Atlanta, Georgia., Horwitz E; Division of Nephrology & Hypertension, MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio., Ix JH; Division of Nephrology-Hypertension, University of California San Diego, Veterans Affairs San Diego Healthcare System, San Diego, California., Tuot DS; Department of Medicine, University of California, San Francisco, San Francisco, California., Ishani A; Division of Nephrology and Hypertension, University of Minnesota, Minneapolis, Minnesota.; Minneapolis VA Health Care System, Minneapolis, Minnesota., Pajewski NM; Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina.

Publikováno v: Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2024 Feb 01; Vol. 19 (2), pp. 213-223. Date of Electronic Publication: 2023 Oct 25.

Effect of Intensive versus Standard BP Control on AKI and Subsequent Cardiovascular Outcomes and Mortality: Findings from the SPRINT EHR Study.

Autor: Drawz PE; Division of Renal Diseases and Hypertension, University of Minnesota Medical School, Minneapolis, Minnesota., Rai NK; Division of Renal Diseases and Hypertension, University of Minnesota Medical School, Minneapolis, Minnesota., Lenoir KM; Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Suarez M; Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida., Powell JR; Division of General Internal Medicine, Brody School of Medicine, East Carolina University, Greenville, North Carolina., Raj DS; Division of Kidney Diseases and Hypertension, George Washington University, Washington, DC., Beddhu S; Division of Nephrology and Hypertension, Department of Internal Medicine, University of Utah Health, Salt Lake City, Utah., Agarwal AK; Department of Medicine, Veterans Affairs Central California Health Care System, Fresno, California., Soman S; Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, Michigan., Whelton PK; Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana., Lash J; Division of Nephrology, University of Illinois at Chicago, Chicago, Illinois., Rahbari-Oskoui FF; Renal Division, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia., Dobre M; Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, Ohio., Parkulo MA; Department of Medicine, Division of Community Internal Medicine, Mayo Clinic, Jacksonville, Florida., Rocco MV; Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina., McWilliams A; Department of Internal Medicine and Center for Outcomes Research and Evaluation, Atrium Health, Charlotte, North Carolina., Dwyer JP; Division of Nephrology & Hypertension, University of Utah Health, Salt Lake City, Utah., Thomas G; Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio., Rahman M; Case Western Reserve University, University Hospitals Cleveland Medical Center, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio., Oparil S; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Horwitz E; Case Western Reserve University, MetroHealth Medical Center, Cleveland, Ohio., Pajewski NM; Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Ishani A; Division of Renal Diseases and Hypertension, University of Minnesota Medical School, Minneapolis, Minnesota.; Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota.

Publikováno v: Kidney360 [Kidney360] 2022 May 10; Vol. 3 (7), pp. 1253-1262. Date of Electronic Publication: 2022 May 10 (Print Publication: 2022).

Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease.

Autor: El Ters M; Division of Nephrology and Hypertension and the Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas, USA.; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA., Lu P; Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas, USA., Mahnken JD; Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas, USA., Stubbs JR; Division of Nephrology and Hypertension and the Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas, USA., Zhang S; Division of Nephrology and Hypertension and the Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas, USA., Wallace DP; Division of Nephrology and Hypertension and the Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas, USA., Grantham JJ; Division of Nephrology and Hypertension and the Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas, USA., Chapman AB; Division of Nephrology, University of Chicago School of Medicine, Chicago, Illinois, USA.; Department of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Torres VE; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA., Harris PC; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA., Bae KT; Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Landsittel DP; Department of Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Rahbari-Oskoui FF; Department of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Mrug M; Division of Nephrology, University of Alabama and the Department of Veterans Affairs Medical Center, Birmingham, Alabama, USA., Bennett WM; Legacy Good Samaritan Hospital, Portland, Oregon, USA., Yu ASL; Division of Nephrology and Hypertension and the Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas, USA.

Publikováno v: Kidney international reports [Kidney Int Rep] 2021 Jan 16; Vol. 6 (4), pp. 953-961. Date of Electronic Publication: 2021 Jan 16 (Print Publication: 2021).

The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD.

Autor: Lavu S; Division of Nephrology and Hypertension., Vaughan LE; Department of Biomedical Statistics and Informatics, and., Senum SR; Division of Nephrology and Hypertension., Kline TL; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Chapman AB; Division of Nephrology, University of Chicago School of Medicine, Chicago, Illinois, USA.; Department of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Perrone RD; Division of Nephrology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA., Mrug M; Division of Nephrology, University of Alabama and Department of Veterans Affairs Medical Center, Birmingham, Alabama, USA., Braun WE; Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, Ohio, USA., Steinman TI; Renal Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Rahbari-Oskoui FF; Department of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Brosnahan GM; Division of Renal Diseases and Hypertension, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, USA., Bae KT; Department of Radiology and., Landsittel D; Center of Research on Health Care, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Chebib FT; Division of Nephrology and Hypertension., Yu AS; Jared Grantham Kidney Institute, Kansas University Medical Center, Kansas, Kansas, USA., Torres VE; Division of Nephrology and Hypertension., Harris PC; Division of Nephrology and Hypertension.

Publikováno v: JCI insight [JCI Insight] 2020 Aug 06; Vol. 5 (15). Date of Electronic Publication: 2020 Aug 06.